(Q36414463)

14 August 2017

1 reference

title

Biochemical markers of hepatic fibrosis (English)

1 reference

14 August 2017

M. Plebani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651819

21 October 2022

A. Burlina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651819

21 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1651819

21 October 2022

publication date

1 June 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:000991209180013S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

https://api.elsevier.com/content/article/PII:000991209180013S?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

published in

Clinical Biochemistry

1 reference

14 August 2017

volume

24

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

219-239

1 reference

Connective tissue components of the normal and fibrotic liver. I. Structure, local distribution and metabolism of connective tissue components in the normal liver and changes in chronic liver diseases

14 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Blood analysis for liver cirrhosis.

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Measurement of connective tissue parameters in serum for diagnosis and follow-up of liver fibrosis

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The extracellular matrix of the liver.

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The rate of synthesis of glycosaminoglycans and collagen by fibroblasts cultured from adult human liver biopsies

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver

21 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in culture

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The molecular biology of platelet-derived growth factor

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The TGF-beta family of growth and differentiation factors.

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Induction of transforming growth factor-alpha in activated human alveolar macrophages

21 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Lymphokine stimulation of collagen accumulation

21 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Acetaldehyde stimulates collagen and noncollagen protein production by human fibroblasts

21 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum selenium in liver cirrhosis: correlation with markers of fibrosis

21 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Secondary oxalosis in chronic renal insufficiency

21 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagen formation and cirrhosis

21 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Current Concepts of Collagen Structure

21 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Adhesion of rat hepatocytes to collagen

21 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Functional correlation between cell adhesive properties and some cell surface proteins

21 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Physiology of Fibronectin

21 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Plasma fibronectin in normal subjects and in various disease states

21 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

Fibronectin in disease

53

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin

21 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Distribution of collagen type I and type III and of two collagenous components of basement membranes in the human liver

21 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Proteoglycan core protein families

21 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Cell-surface glycosaminoglycans

21 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The rate of synthesis of glycosaminoglycans and collagen by fibroblasts cultured from adult human liver biopsies

21 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Concentration of sodium hyaluronate in serum

21 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase

21 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. II. Galactosylhydroxylysyl glucosyltransferase

21 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagenases (first of three parts).

21 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The biosynthesis of collagen and its disorders (first of two parts).

21 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Three conformationally distinct domains in the amino-terminal segment of type III procollagen and its rapid triple helix leads to and comes from coil transition

21 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Biosynthesis of Procollagen

21 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Changes of collagen types at various stages of human liver cirrhosis

21 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Increase in type I and type III collagens in human alcoholic liver cirrhosis

21 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Evaluation of serum aminoterminal procollagen type III propeptide as an index of portal hypertension and esophageal varices in chronic liver diseases

21 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Radioimmunoassay for type III procollagen peptide and its application to human liver disease

21 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum

21 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Immunochemical properties of the aminopropeptide of procollagen type III.

21 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments

21 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides

21 October 2022

84

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis

21 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity

21 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum procollagen type III peptide levels in patients with acute viral hepatitis

21 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum procollagen III N-terminal peptide and laminin P1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis

21 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload

21 October 2022

92

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Procollagen III peptide and fibronectin in alcohol-related chronic liver disease: correlations with morphological features and biochemical tests

21 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis

21 October 2022

95

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum marker of type III procollagen in patients with idiopathic hemochromatosis and its relationship to hepatic fibrosis

21 October 2022

96

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis

21 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis

21 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases

21 October 2022

100

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?

21 October 2022

101

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease

21 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease

21 October 2022

105

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis.

21 October 2022

106

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

A radioimmunoassay procedure for type III procollagen: its use in the detection of hepatic fibrosis

21 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients

21 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease

21 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis

21 October 2022

110

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis

21 October 2022

114

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis

21 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum Levels of Type I and III Procollagen Fragments in Paget's Disease of Bone*

21 October 2022

116

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma

21 October 2022

117

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis

21 October 2022

118

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance

21 October 2022

119

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases

21 October 2022

120

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Elevated ratios of type I/III collagen in the lungs of chronically ventilated neonates with respiratory distress

21 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease

21 October 2022

122

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions

21 October 2022

123

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine

21 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Markers of collagen metabolism in sera of patients with various rheumatic diseases

21 October 2022

125

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum

21 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Radioimmunoassay for Human Procollagen

21 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Radioimmunoassay for the aminoterminal peptide of procollagen p alpha 1(I)-chain

21 October 2022

129

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Characterization of the Amino-Terminal Segment in Type III Procollagen

21 October 2022

130

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

A Monoclonal Antibody Specific for the Amino Terminal Cleavage Site of Procollagen Type I

21 October 2022

132

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Procollagen type I production by hepatocytes: a marker of progressive liver disease?

21 October 2022

133

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

A network model for the organization of type IV collagen molecules in basement membranes

21 October 2022

135

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease

21 October 2022

136

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease

21 October 2022

137

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Sensitive radioimmunoassays for 7 S collagen and laminin: Application to serum and tissue studies of basement membranes

21 October 2022

138

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease

21 October 2022

139

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Binding domain for laminin on type IV collagen

21 October 2022

143

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Laminin binds specifically to sulfated glycolipids

21 October 2022

144

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Substrate adhesion of rat hepatocytes: a comparison of laminin and fibronectin as attachment proteins

21 October 2022

145

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin

21 October 2022

146

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic fibrosis. Correlation of biochemical and morphologic investigations

21 October 2022

151

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix

21 October 2022

153

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane

21 October 2022

155

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Sensitive radioimmunoassays for 7 S collagen and laminin: Application to serum and tissue studies of basement membranes

21 October 2022

158

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment

21 October 2022

159

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Glomerular basement membrane synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats

21 October 2022

160

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type IV collagen antigens in serum of diabetic rats: a marker for basement membrane collagen biosynthesis

21 October 2022

161

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Immunochemical and autoantigenic properties of the globular domain of basement membrane collagen (type IV)

21 October 2022

163

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease

21 October 2022

165

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases

21 October 2022

166

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Physiology of Fibronectin

21 October 2022

169

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

Fibronectin in disease

170

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Affinity of fibronectin to collagens of different genetic types and to fibrinogen

21 October 2022

171

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.

21 October 2022

173

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Plasma fibronectin in liver cirrhosis and its diagnostic value

21 October 2022

174

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Distribution of fibronectin in plasma and liver in liver diseases

21 October 2022

175

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Fibronectin decrease in liver cirrhosis is related to spleen size

21 October 2022

177

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Low fibronectin in portal hypertension

21 October 2022

178

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Plasma fibronectin in normal subjects and in various disease states

21 October 2022

180

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit

21 October 2022

182

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ

21 October 2022

183

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum hyaluronate in liver diseases: study by enzymoimmunological assay

21 October 2022

184

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver

21 October 2022

185

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells

21 October 2022

186

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study.

21 October 2022

187

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Determination of hyaluronate in biological samples by a specific radioassay technique

21 October 2022

188

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Quantitative analysis of hyaluronate in nanogram amounts

21 October 2022

189

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Concentration of sodium hyaluronate in serum

21 October 2022

190

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage

21 October 2022

192

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis

21 October 2022

193

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Effect of connective tissue intercellular matrix on lymphocyte stimulation

21 October 2022

196

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

The biosynthesis of collagen and its disorders (first of two parts).

21 October 2022

198

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

An Affinity-Column Procedure Using Poly(l-proline) for the Purification of Prolyl Hydroxylase. Purification of the Enzyme from Chick Embryos

21 October 2022

199

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Human Prolyl Hydroxylase. Purification, Partial Characterization and Preparation of Antiserum to the Enzyme

21 October 2022

200

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Purification and properties of collagen proline hydroxylase from newborn rat skin

21 October 2022

201

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Prolyl hydroxylase and an immunologically related protein in mammalian tissues

21 October 2022

204

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Developmental Changes in Prolyl Hydroxylase Activity and Protein in Chick Embryo

21 October 2022

205

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Immunoreactive prolyl hydroxylase in human skin, serum and synovial fluid: changes in the content and components with age

21 October 2022

206

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth

21 October 2022

209

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Proline-hydroxylase activity in human blood.

21 October 2022

213

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury

21 October 2022

214

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Intracellular enzymes of collagen biosynthesis in rat liver as a function of age and in hepatic injury induced by dimethylnitrosamine. Purification of rat prolyl hydroxylase and comparison of changes in prolyl hydroxylase activity with changes in im

21 October 2022

215

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Radioimmunoassay for Human and Chick Prolyl Hydroxylases

21 October 2022

216

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum immunoreactive prolyl hydroxylase in liver disease

21 October 2022

217

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

A sandwich immunoassay for human prolyl 4-hydroxylase using monoclonal antibody

21 October 2022

218

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Immunological properties of monoclonal antibodies to human and rat prolyl 4-hydroxylase

21 October 2022

219

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic collagen proline hydroxylase activity in primary biliary cirrhosis

21 October 2022

222

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic collagen proline hydroxylase activity in hepatic disease following jejunoileal bypass for morbid obesity

21 October 2022

223

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic prolyl hydroxylase activity in human liver disease

21 October 2022

224

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease

21 October 2022

226

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic collagen proline hydroxylase activity in alcoholic liver disease

21 October 2022

227

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Hepatic Peptidyl Prolyl Hydroxylase Activity and Liver Fibrosis-A Prospective Study of 94 Infants and Children with Hepatobiliary Disorders

21 October 2022

228

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases

21 October 2022

231

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Studies on serum immunoreactive prolyl 4-hydroxylase in liver diseases--its elevation both in hepatocellular damage and cholestatic diseases

21 October 2022

232

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Human prolyl hydroxylase. Purification, radioimmunoassay and clinical studies in liver diseases

21 October 2022

233

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Proline-hydroxylase activity in human blood.

21 October 2022

234

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

Lysyl Oxidase

235

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Biosynthesis of Collagen Crosslinks: Increased Activity of Purified Lysyl Oxidase with Reconstituted Collagen Fibrils

21 October 2022

236

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Biosynthesis of collagen and its alterations in pathological states

21 October 2022

240

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

A Clinical Evaluation of Serum Monoamine Oxidase, with Special Reference to Hepatic Fibrosis

21 October 2022

242

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Comparative studies on human plasma monoamine oxidase in normal subjects and in fibrotic liver disease

21 October 2022

244

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Isoenzyme Composition of Human Plasma Monoamine Oxidase in Normal Subjects and in Fibrotic Liver Disease

21 October 2022

246

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum monoamine oxidase assayed with a new synthetic benzylamine derivative as substrate. Its clinical significance with special reference to hepatic fibrosis

21 October 2022

248

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Validity of monoamine oxidase in serum for diagnosis of liver cirrhosis: estimation of predictive values, sensitivities and specificities

21 October 2022

249

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

liver cirrhosis

250

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Activity of procollagen-prolyl-hydroxylase and N-acetyl-?-glucosaminidase in liver biopsies from patients with chronic liver diseases

21 October 2022

252

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients

21 October 2022

257

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Predictive values of serum N-acetyl-beta-D-glucosaminidase for fibrotic liver disorders--correlation with monoamine oxidase activity

21 October 2022

258

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases

21 October 2022

260

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

[Isoenzyme P of N-acetyl-beta-glucosaminidase in sera from patients with liver diseases (author's transl)]

21 October 2022

265

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagenase activity in experimental hepatic fibrosis

21 October 2022

266

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagenase in experimental carbon tetrachloride cirrhosis of the liver

21 October 2022

267

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Collagenases in mammalian cells

21 October 2022

271

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases

21 October 2022

273

1 reference

https://api.crossref.org/works/10.1016/0009-9120(91)80013-S

21 October 2022

Identifiers

1 reference

14 August 2017

1 reference